Physician profile
Heloise Westbrook
NPI 1952413015
$6,463.15
in general payments reported to CMS, 2019-2025
15 companies · $645 in 2025
The $645 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,984 · 2020: $220 · 2021: $29.43 · 2022: $585 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $411 · Food and Beverage: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $411.20 |
| Food and Beverage | $233.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,177.21 | 2019 | |
| Medtronic, INC. | $1,153.60 | 2022-2025 | Kyphon Express II Kyphopak Tray, Pteye Parathyroid Detection System, Inceptiv |
| Boston Scientific Corporation | $1,005.12 | 2019-2020 | |
| Stryker Corporation | $847.55 | 2019 | |
| Stimwave Technologies Incorporated | $542.94 | 2019 | |
| Nevro Corp. | $460.76 | 2019-2021 | |
| Grt US Holding, INC. | $75.91 | 2022 | |
| Flowonix Medical Incorporated | $73.77 | 2019 | |
| Daiichi Sankyo INC. | $46.48 | 2019 | |
| Collegium Pharmaceutical, INC. | $23.87 | 2019 | |
| Si-Bone, INC. | $14.94 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $14.30 | 2021 | |
| Vertos Medical, INC. | $12.19 | 2019 | |
| Biodelivery Sciences International, INC. | $11.13 | 2019 | |
| Epimed International, INC | $3.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heloise Westbrook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.